Noninvasive Prenatal Test Results Indicative of Maternal Malignancies: A Nationwide Genetic and Clinical Follow-Up Study
Conception and design: Catharina J. Heesterbeek, Robert-Jan H. Galjaard, Christine E.M. de Die-Smulders, Vivianne C.G. Tjan-Heijnen, Lidewij Henneman, Erik A. Sistermans, Merryn V.E. Macville
Administrative support: Christine E.M. de Die-Smulders, Erik A. Sistermans, Vivianne C.G. Tjan-Heijnen, Lidewij Henneman, Merryn V.E. Macville
Provision of study materials or patients: Elles M.J. Boon, Malgorzata I. Srebniak, Katelijne Bouman, Brigitte H.W. Faas, Lutgarde C.P. Govaerts, Mariëtte J.V. Hoffer, Nicolette S. den Hollander, Klaske D. Lichtenbelt, Merel C. van Maarle, Lisanne van Prooyen Schuurman, Maartje C. van Rij, Heleen Schuring-Blom, Gita Tan-Sindhunata, Christine E.M. de Die-Smulders, Erik A. Sistermans, Merryn V.E. Macville
Collection and assembly of data: Catharina J. Heesterbeek, Sietse M. Aukema, Robert-Jan H. Galjaard, Elles M.J. Boon, Malgorzata I. Srebniak, Katelijne Bouman, Lutgarde C.P. Govaerts, Mariëtte J.V. Hoffer, Nicolette S. den Hollander, Klaske D. Lichtenbelt, Merel C. van Maarle, Lisanne van Prooyen Schuurman, Maartje C. van Rij, G. Heleen Schuring-Blom, Gita Tan-Sindhunata, Christine E.M. de Die-Smulders, Merryn V.E. Macville
Data analysis and interpretation: Catharina J. Heesterbeek, Sietse M. Aukema, Elles M.J. Boon, Malgorzata I. Srebniak, Brigitte H.W. Faas, Servi J.C. Stevens, Masoud Zamani Esteki, Christine E.M. de Die-Smulders, Vivianne C.G. Tjan-Heijnen, Erik A. Sistermans, Merryn V.E. Macville
Manuscript writing: All authors
Final approval of manuscript: All authors
Accountable for all aspects of the work: All authors
AUTHORS’ DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST
Noninvasive Prenatal Test Results Indicative of Maternal Malignancies: A Nationwide Genetic and Clinical Follow-Up Study
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO’s conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/jco/authors/author-center.
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments).
Vivianne C.G. Tjan-Heijnen
Honoraria: Novartis, Roche, Lilly, AstraZeneca
Consulting or Advisory Role: Pfizer, Lilly, Accord Healthcare, Novartis
Research Funding: Roche (Inst), Eisai (Inst), Pfizer (Inst), Novartis (Inst), Lilly (Inst), Daiichi Sankyo/Astra Zeneca (Inst), Gilead Sciences (Inst)
Merryn V.E. Macville
Other Relationship: Natl Institiute for Public Health & Environment (RIVM)—Center for Population Screening (CvB), Dutch NIPT Consortium, Netherlands Organization for Health Research and Development (ZonMW) (Inst)
Uncompensated Relationships: Illumina (Inst)
No other potential conflicts of interest were reported.
